Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-23816813

ABSTRACT

Taking into account that pro-inflammatory cytokines and oxidative and nitrosative stress are implicated in the pathogenesis of depression and that α-tocopherol has antidepressant, anti-inflammatory and antioxidant properties, this study investigated the ability of α-tocopherol to abolish the depressive-like behavior induced by i.c.v. administration of TNF-α in the mouse TST. Additionally, we investigated the occurrence of changes in the levels of Bcl2 and Bax and phosphorylation of GSK-3ß (Ser9) in the hippocampus of mice. The administration of TNF-α (0.001fg/site, i.c.v.) increased the immobility time in the TST, which was prevented by the administration of α-tocopherol at the doses of 10, 30 and 100mg/kg (p.o.). Subeffective doses of α-tocopherol (10mg/kg, p.o.) and/or the antidepressants fluoxetine (5mg/kg, p.o.), imipramine (0.1mg/kg, p.o.) and bupropion (1mg/kg, p.o.), the NMDA receptor antagonist MK-801 (0.001mg/kg, p.o.) or the neuronal nitric oxide synthase inhibitor 7-nitroindazole (25mg/kg, i.p.) prevented the depressive-like effect induced by TNF-α. None of the treatments altered the locomotor activity of mice. Treatment with TNF-α and/or α-tocopherol did not alter the levels of Bax and Bcl2 or the phosphorylation of GSK-3ß in the hippocampus of mice. Together, our results show a synergistic antidepressant-like effect of α-tocopherol with antidepressants against the depressive-like behavior induced by an inflammatory insult, suggesting that this vitamin may be useful to optimize conventional pharmacotherapy of depression, including depressive states associated with inflammatory conditions.


Subject(s)
Antidepressive Agents/therapeutic use , Depressive Disorder/chemically induced , Depressive Disorder/drug therapy , Disease Models, Animal , Tumor Necrosis Factor-alpha/toxicity , alpha-Tocopherol/therapeutic use , Animals , Depressive Disorder/psychology , Female , Mice , Treatment Outcome
2.
Eur J Appl Physiol ; 112(1): 387-96, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21573779

ABSTRACT

The present study investigates the effects of incremental exercise test on muscular oxidative metabolism. Thirty-six 2-month-old male Wistar rats were distributed in seven groups that performed exercise at different levels: first level (control), second level (0.6 km/h), third level (0.6 and 0.8 km/h), fourth level (0.6, 0.8 and 1.0 km/h), fifth level (0.6, 0.8, 1.0 and 1.2 km/h), sixth level (0.6, 0.8, 1.0, 1.2 and 1.4 km/h), and seventh level (0.6, 0.8, 1.0, 1.2, 1.4 and 1.6 km/h). At the end of the exercise challenge, level of blood lactate (BL), glycogen content (MG), creatine kinase (CK), complexes (CI, CII, CIII, CIV), oxidative damage, succinate dehydrogenase (SDH), cytochrome c oxidase as well as antioxidant enzymes (SOD and CAT) expression were measured. The speed of 1.0 km/h increased BL level, while 1.2 km/h decreased MG and increased serum CK. Increased SDH expression was observed after intensity levels 6 and 7, and cytochrome c oxidase expression increased after levels 5, 6 and 7, in comparison with lower intensity levels, ETC enzyme activities increased when exercise was applied at intensities of 0.8 km/h (CI), 1.0 km/h (CII and CIII), and 1.2 km/h (CIV). The increase in SOD expression did not occur as observed for superoxide production, except for rats that underwent exercise at level 7, but CAT expression increased significantly in all levels, starting from level 3. Our results show interesting alterations in the muscular metabolism parameters, and suggest a differential response of muscle oxidative metabolism when intense exercise is applied at different speeds.


Subject(s)
Muscle Contraction/physiology , Muscle, Skeletal/physiology , Oxygen Consumption/physiology , Physical Conditioning, Animal/methods , Physical Exertion/physiology , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism , Animals , Exercise Test , Male , Oxidation-Reduction , Rats , Rats, Wistar
3.
J Neural Transm (Vienna) ; 119(4): 481-91, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21953515

ABSTRACT

Several studies have appointed for a role of glutamatergic system and/or mitochondrial function in major depression. In the present study, we evaluated the creatine kinase and mitochondrial respiratory chain activities after acute and chronic treatments with memantine (N-methyl-D: -aspartate receptor antagonist) and imipramine (tricyclic antidepressant) in rats. To this aim, rats were acutely or chronically treated for 14 days once a day with saline, memantine (5, 10 and 20 mg/kg) and imipramine (10, 20 and 30 mg/kg). After acute or chronic treatments, we evaluated mitochondrial respiratory chain complexes (I, II, II-III and IV) and creatine kinase activities in prefrontal cortex, hippocampus and striatum. Our results showed that both acute and chronic treatments with memantine or imipramine altered respiratory chain complexes and creatine kinase activities in rat brain; however, these alterations were different with relation to protocols (acute or chronic), complex, dose and brain area. Finally, these findings further support the hypothesis that the effects of imipramine and memantine could be involve mitochondrial function modulation.


Subject(s)
Adrenergic Uptake Inhibitors/pharmacology , Brain , Creatine Kinase/metabolism , Dopamine Agents/pharmacology , Imipramine/pharmacology , Memantine/pharmacology , Multienzyme Complexes/metabolism , Analysis of Variance , Animals , Brain/anatomy & histology , Brain/drug effects , Brain/enzymology , Dose-Response Relationship, Drug , Male , NADH Dehydrogenase/metabolism , Rats , Rats, Wistar , Time Factors
4.
Mol Cell Biochem ; 350(1-2): 149-54, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21203802

ABSTRACT

Hepatic encephalopathy is an important cause of morbidity and mortality in patients with severe hepatic failure. This disease is clinically characterized by a large variety of symptoms including motor symptoms, cognitive deficits, as well as changes in the level of alertness up to hepatic coma. Acetaminophen is frequently used in animals to produce an experimental model to study the mechanisms involved in the progression of hepatic disease. The brain is highly dependent on ATP and most cell energy is obtained through oxidative phosphorylation, a process requiring the action of various respiratory enzyme complexes located in a special structure of the inner mitochondrial membrane. In this context, the authors evaluated the activities of mitochondrial respiratory chain complexes in the brain of rats submitted to acute administration of acetaminophen and treated with the combination of N-acetylcysteine (NAC) plus deferoxamine (DFX) or taurine. These results showed that acetaminophen administration inhibited the activities of complexes I and IV in cerebral cortex and that the treatment with NAC plus DFX or taurine was not able to reverse this inhibition. The authors did not observe any effect of acetaminophen administration on complexes II and III activities in any of the structures studied. The participation of oxidative stress has been postulated in the hepatic encephalopathy and it is well known that the electron transport chain itself is vulnerable to damage by reactive oxygen species. Since there was no effect of NAC + DFX, the effect of acetaminophen was likely to be due to something else than oxidative stress.


Subject(s)
Acetaminophen , Brain/drug effects , Electron Transport/drug effects , Liver Failure/chemically induced , Mitochondria/drug effects , Acetylcysteine/pharmacology , Analgesics, Non-Narcotic , Animals , Antioxidants/pharmacology , Brain/metabolism , Brain/physiology , Deferoxamine/pharmacology , Down-Regulation/drug effects , Drug Evaluation, Preclinical , Electron Transport/physiology , Liver Failure/metabolism , Liver Failure/physiopathology , Male , Mitochondria/metabolism , Rats , Rats, Wistar , Taurine/pharmacology
5.
Basic Clin Pharmacol Toxicol ; 108(3): 214-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21138529

ABSTRACT

The pathophysiology of gastritis involves an imbalance between gastric acid attack and mucosal defence. In addition, the gastric mucosal injury results in adenosine triphosphate (ATP) depletion leading to mitochondrial dysfunction. Several studies have shown the association of mitochondrial disorders with gastrointestinal dysfunction. In the present study, we investigated the activity of mitochondrial respiratory chain complexes activity in the stomach of rats with gastritis induced by indomethacin (IDM) and treated with omeprazole (OM), N-acetylcysteine (NAC) and the gastrin-releasing peptide receptor (GRPR) antagonist RC-3095. Adult male Wistar rats were pre-treated for 7 days with OM, NAC, RC-3095, combination of OM plus RC-3095, OM plus NAC and water (control). The animals were then submitted to fasting for 24 hr; IDM was administered. The rats were killed 6 hr later, and the stomachs were used for evaluation of macroscopic damage and respiratory chain activity. Our results showed that complex I and IV activities were not affected by administration of IDM. On the other hand, complex II and III activities were inhibited. In addition, OM plus RC-3095 and OM plus NAC did not reverse complex II activity inhibition. However, the complex III activity inhibition was reversed only with the combined use of OM plus RC-3095 and OM plus NAC. Our results are in agreement with previous studies indicating mitochondrial dysfunction in the pathophysiology of gastrointestinal tract disease and we suggest that GRPR antagonism might be a novel therapeutic strategy in gastritis.


Subject(s)
Acetylcysteine/pharmacology , Anti-Ulcer Agents/pharmacology , Bombesin/analogs & derivatives , Electron Transport Complex II/metabolism , Gastritis/metabolism , Omeprazole/pharmacology , Peptide Fragments/pharmacology , Receptors, Bombesin/antagonists & inhibitors , Acetylcysteine/therapeutic use , Animals , Anti-Inflammatory Agents, Non-Steroidal/toxicity , Anti-Ulcer Agents/therapeutic use , Bombesin/pharmacology , Bombesin/therapeutic use , Drug Therapy, Combination , Electron Transport/drug effects , Electron Transport Complex II/antagonists & inhibitors , Electron Transport Complex III/antagonists & inhibitors , Electron Transport Complex III/metabolism , Gastric Mucosa/metabolism , Gastritis/pathology , Gastritis/prevention & control , Indomethacin/toxicity , Male , Mitochondria/drug effects , Mitochondria/enzymology , Omeprazole/therapeutic use , Peptide Fragments/therapeutic use , Proton Pump Inhibitors/pharmacology , Proton Pump Inhibitors/therapeutic use , Rats , Rats, Wistar , Severity of Illness Index , Stomach/drug effects , Stomach/pathology , Stomach Ulcer/prevention & control
6.
Neurochem Res ; 36(2): 304-11, 2011 02.
Article in English | MEDLINE | ID: mdl-21107688

ABSTRACT

Sepsis is characterized by biochemical alterations in the central nervous system at early times and cognitive impairment at late times after induction in sepsis animal model. In order to understand at least in part the mechanism of disease, we have evaluated the effects of sepsis on cytokine levels in the cerebrospinal fluid (CSF); oxidative parameters; the activity of the electron transport chain enzymes; and creatine kinase (CK) activity in the brain of sepsis survivor rats 10 days after cecal ligation and perforation (CLP). Male Wistar rats underwent CLP with "basic support" or sham-operated. Ten days after surgery, the animals were killed and prefrontal cortex, cortex, hippocampus, striatum, cerebellum, and CSF were obtained. It was found a decrease in the levels of TNF-α (P = 0.001), IL-1ß (P = 0.008), IL-6 (P = 0.038), and IL-10 (P = 0.022) in the CSF; an increase in the TBARS only hippocampus (0.027); an up-regulation in the activity of complex II (P = 0.024), III (P = 0.018), and IV (P = 0.047) only in the prefrontal cortex; a decrease in the CK activity in the cerebellum (P = 0.001) and striatum (P = 0.0001), and an increase in the hippocampus (P = 0.0001) and cortex (P = 0.0001). Oxidative stress and mitochondrial alterations observed during early times in sepsis, persisted up to 10 days after surgery. The cytokines levels during the early times were found at high levels, decreasing to low levels after 10 days. In conclusion, these findings may contribute for a better comprehension of the cognitive damage in sepsis survivor rats.


Subject(s)
Brain/metabolism , Energy Metabolism/physiology , Inflammation Mediators/metabolism , Oxidative Stress , Sepsis/metabolism , Sepsis/physiopathology , Animals , Brain/physiopathology , Creatine Kinase/metabolism , Cytokines/metabolism , Electron Transport Chain Complex Proteins/metabolism , Humans , Male , Mitochondria/metabolism , Rats , Rats, Wistar , Thiobarbituric Acid Reactive Substances/metabolism
7.
Brain Res Bull ; 82(5-6): 302-7, 2010 Jul 30.
Article in English | MEDLINE | ID: mdl-20576495

ABSTRACT

The brain is highly dependent on ATP and most cell energy is obtained through oxidative phosphorylation, a process requiring the action of various respiratory enzyme complexes located in a special structure of the inner mitochondrial membrane. Bacterial meningitis due to Streptococcus pneumoniae is associated with a significant mortality rate and persisting neurologic sequelae including sensory-motor deficits, seizures, and impairments of learning and memory. In this context, we evaluated the activities of mitochondrial respiratory chain complexes in the brain of rats submitted to meningitis by S. pneumoniae inoculation into the cisterna magna. Our results demonstrated that complex I activity was not altered in cerebral cortex after meningitis; complexes II, III and IV were increased 24 and 48h after meningitis. We have also verified that complex I was inhibited in prefrontal cortex 48h after meningitis; complexes II, III and IV were not altered. Our results also demonstrated that complex I activity was inhibited in striatum, hippocampus and cerebellum 24h after meningitis. Moreover, complex II activity was increased in hippocampus and striatum 24 and 48h after meningitis; complexes III and IV activity were increased in striatum, hippocampus and cerebellum 48h after meningitis. Taking together previous reports and our present findings, we speculate that oxidative stress and metabolism impairment might contribute, at least in part, for the pathogenesis of pneumococcal meningitis.


Subject(s)
Brain/enzymology , Brain/pathology , Electron Transport Chain Complex Proteins/metabolism , Meningitis, Pneumococcal/pathology , Mitochondria/enzymology , Animals , Brain/microbiology , Disease Models, Animal , Electron Transport/physiology , Male , Meningitis, Pneumococcal/physiopathology , Rats , Rats, Wistar
8.
Metab Brain Dis ; 25(2): 219-25, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20424907

ABSTRACT

We evaluated the activities of mitochondrial respiratory chain complexes in the brain of rats after renal ischemia and the effect of administration of the antioxidants N-acetylcysteine (NAC) and deferoxamine (DFX). The rats were divided into the groups: sham (control) or renal ischemia treated with saline, NAC 20 mg/kg, DFX 20 mg/kg or both antioxidants. Complex I activity was inhibited in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 1 and 6 h after renal ischemia and that the treatment with a combination of NAC and DFX prevented such effect. Complex I activity was not altered in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 12 h after renal ischemia. Complexes II and III activities were not altered in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 1, 6 and 12 h after renal ischemia. Complex IV activity was inhibited in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 1 h after renal ischemia, but the treatment with the combination of NAC and DFX was able to prevent this inhibition. Complex IV activity was not altered in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 6 and 12 h after renal ischemia. These results suggest that the inhibition of mitochondrial respiratory chain after renal ischemia might play a role in the pathogenesis of uremic encephalopathy.


Subject(s)
Acetylcysteine/pharmacology , Deferoxamine/pharmacology , Electron Transport Complex I/drug effects , Electron Transport/drug effects , Ischemia/metabolism , Ischemia/prevention & control , Kidney Diseases/metabolism , Kidney Diseases/prevention & control , Animals , Cell Respiration/drug effects , Cell Respiration/physiology , Disease Models, Animal , Drug Combinations , Drug Synergism , Electron Transport/physiology , Electron Transport Complex I/metabolism , Free Radical Scavengers/pharmacology , Ischemia/etiology , Kidney Diseases/complications , Male , Rats , Rats, Wistar
9.
Acta Neuropsychiatr ; 22(6): 292-9, 2010 Dec.
Article in English | MEDLINE | ID: mdl-25385216

ABSTRACT

UNLABELLED: Rezin GT, Gonçalves CL, Daufenbach JF, Carvalho-Silva M, Borges LS, Vieira JS, Hermani FV, Comim CM, Quevedo J, Streck EL. Effect of chronic administration of ketamine on the mitochondrial respiratory chain activity caused by chronic mild stress. OBJECTIVE: Recently, we reported that mitochondrial respiratory chain complexes I, III and IV were inhibited in the cerebral cortex and cerebellum of rats submitted to chronic mild stress (CMS) and that acute ketamine administration reversed this effect. Therefore, we investigated whether the inhibition of these enzymes may be reversed by chronic administration of ketamine. METHODS: Adult male Wistar rats were submitted to CMS and chronically treated with ketamine. After 40 days of CMS, consumption of sweet food, adrenal gland weight, body weight and enzymatic activity of the complexes were measured. RESULTS: We verified that CMS decreased the intake of sweet food, increased the adrenal gland weight and the control group gained weight after 40 days but the stressed group did not; ketamine administration reversed these effects. We also verified that chronic administration of ketamine reversed the inhibition of complexes I, III and IV in cerebral cortex. However, in cerebellum, only complex IV inhibition was reversed. The chronic ketamine administration partially reverses the inhibition caused by CMS. CONCLUSION: We hypothesise that CMS inhibits complexes I, III and IV activities and that chronic administration of ketamine administration partially reverses such an effect. Therefore, it seems reasonable to propose that ketamine administration might be a useful therapy for patients affected by major depression.

10.
Brain Res Bull ; 80(1-2): 75-8, 2009 Aug 28.
Article in English | MEDLINE | ID: mdl-19406217

ABSTRACT

Hepatic encephalopathy is an important cause of morbidity and mortality in patients with severe hepatic failure. This disease is clinically characterized by a large variety of symptoms including motor symptoms, cognitive deficits, as well as changes in the level of alertness up to hepatic coma. Carbon tetrachloride is frequently used in animals to produce an experimental model to study the mechanisms involved in the progression of hepatic disease and the impact of various drugs on this progression. The brain is highly dependent on ATP and most cell energy is obtained through oxidative phosphorylation, a process requiring the action of various respiratory enzyme complexes located in a special structure of the inner mitochondrial membrane. In this context, we evaluated the activities of mitochondrial respiratory chain complexes in the brain of rats submitted to acute administration of carbon tetrachloride and treated with NAC and DFX alone or in combination. Our results showed that complexes I, II and IV were inhibited after carbon tetrachloride administration and that NAC and DFX alone or in combination were able to prevent the inhibition of these enzymes. On the other hand, complex III was not affected. The participation of oxidative stress has been postulated in the hepatic encephalopathy and it is well known that the electron transport chain itself is vulnerable to damage by this species. Based on our findings, we suggest that oxidative stress may be involved in the inhibition of complexes from mitochondrial respiratory chain.


Subject(s)
Antioxidants/therapeutic use , Brain/metabolism , Carbon Tetrachloride/toxicity , Electron Transport/physiology , Enzyme Inhibitors/metabolism , Liver Failure , Mitochondria/metabolism , Animals , Brain/cytology , Electron Transport Chain Complex Proteins/antagonists & inhibitors , Electron Transport Chain Complex Proteins/metabolism , Humans , Liver Failure/chemically induced , Liver Failure/drug therapy , Liver Failure/metabolism , Male , Oxidative Phosphorylation , Oxidative Stress , Rats , Rats, Wistar
11.
Brain Res Bull ; 79(6): 418-21, 2009 Aug 14.
Article in English | MEDLINE | ID: mdl-19393724

ABSTRACT

Modulation and dysfunction of the glutamatergic system seems to be involved in depression. Recently a renewed interest in the glutamatergic system as a treatment option for major depression emerged by the finding that the glutamate N-methyl-D-aspartate (NMDA) antagonist ketamine leads to a rapid improvement of depressive symptoms. Several works support the hypothesis that metabolism impairment is involved in the pathophysiology of depression. We have also recently reported that mitochondrial respiratory chain complexes I, III and IV were inhibited in cerebral cortex and cerebellum of rats after 40 days of chronic mild stress (CMS), which is used as an animal model of depression. Thus, we investigated whether the inhibition of these enzymes may be reversed by acute administration of ketamine (15 mg/kg). We verified that CMS decreased the intake of sweet food and ketamine was not able to reverse such effect. Adrenal gland weight was increased in stressed rats and ketamine reversed this alteration. Control group gained weight after 40 days but stressed group did not gain weight after the same period. Stressed animals gained weight after acute administration of ketamine, when compared to the body weight assessed at the beginning of the experiment. Finally, we verified that complexes I, III and IV were inhibited after CMS in cerebral cortex and cerebellum and acute administration of ketamine reversed this inhibition. Based on the present findings, we hypothesized that CMS induces inhibition of mitochondrial respiratory chain (complexes I, III and IV) and that acute administration of ketamine reverses such effect.


Subject(s)
Excitatory Amino Acid Antagonists/pharmacology , Ketamine/pharmacology , Mitochondria/drug effects , Mitochondria/enzymology , Stress, Psychological/drug therapy , Stress, Psychological/enzymology , Adrenal Glands/drug effects , Adrenal Glands/pathology , Animals , Body Weight/drug effects , Cerebellum/drug effects , Cerebellum/enzymology , Cerebral Cortex/drug effects , Cerebral Cortex/enzymology , Eating/drug effects , Electron Transport/drug effects , Electron Transport/physiology , Electron Transport Complex I/metabolism , Electron Transport Complex III/metabolism , Electron Transport Complex IV/metabolism , Male , Organ Size , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Stress, Psychological/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...